Anjali Singh, Sanket Koul

'Aim to be among top three biosimilar players in world'

Rediff.com 30 Nov 2023

'We've got a huge track record and success in bringing several biosimilars to the market.'

Mankind Pharma sees 21% profit surge in Q2 despite consumer health hurdles

Rediff.com 20 Nov 2023

Pharmaceuticals major Mankind Pharma reported a 21 per cent year-on-year (Y-o-Y) increase in net profit, with revenue rising by 12 per cent Y-o-Y in the second quarter of the financial year 2024 (Q2FY24) in a regulatory filing lrecently.

Heart Disease: Why Young Women Are At Risk

Rediff.com 17 Nov 2023

Practo has witnessed a 215% increase in total consultations related to cardiovascular health, with women in the age group of 25 to 34 contributing to the largest number of consultations.

IKS Health, backed by Jhunjhunwala family, buys US tech firm for Rs 1,600 cr

Rediff.com 1 Nov 2023

AQuity Solutions is a leading tech-enabled clinical documentation, medical coding and revenue integrity solutions provider in the healthcare domain. On the other hand, IKS Health provides administrative, clinical and operational services to clinicians.

Israel conflict unlikely to impact trade of pharma firms

Rediff.com 12 Oct 2023

Indian pharmaceutical firms foresee minimal disruptions in trade with Israel despite escalating regional tensions. Rising crude prices and export shipping insurance premiums have raised concerns, but the pharmaceutical sector remains optimistic. Pharmaceutical exports from India to Israel in FY 2020-21 amounted to $32.5 million, which represents only a minor segment of India's overall pharma exports.